NASDAQ:DRTSW Alpha Tau Medical (DRTSW) Stock Price, News & Analysis → Discover How to Turn $10,000 into $1 Million (From Paradigm Press) (Ad) Free DRTSW Stock Alerts $0.25 -0.01 (-3.88%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.25▼$0.2650-Day Range$0.19▼$0.2752-Week Range$0.14▼$0.40Volume5,378 shsAverage Volume9,399 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Alpha Tau Medical alerts: Email Address Ad Porter & CompanyTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. About Alpha Tau Medical Stock (NASDAQ:DRTSW)Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.Read More DRTSW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DRTSW Stock News HeadlinesMay 20, 2024 | investorplace.comDRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q1 2024April 17, 2024 | msn.comAlpha Tau Medical (DRTS) Price Target Decreased by 11.90% to 9.44March 9, 2024 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateMarch 8, 2024 | investorplace.comDRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023February 23, 2024 | finance.yahoo.comAlpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth PlansJanuary 22, 2024 | msn.comIs Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year?January 13, 2024 | finance.yahoo.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) most popular amongst retail investors who own 58%, insiders hold 22%December 29, 2023 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS) Dividends: History, Yield and DatesDecember 15, 2023 | markets.businessinsider.comExpert Ratings for Alpha Tau MedicalNovember 29, 2023 | finance.yahoo.comAlpha Tau to Participate in Sidoti Small-Cap ConferenceNovember 22, 2023 | msn.comDown -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)November 20, 2023 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 19, 2023 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS), Analyst Ratings, Price Targets, PredictionsNovember 16, 2023 | finance.yahoo.comAlpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 1, 2023 | finance.yahoo.comAlpha Tau to Participate in November Investor ConferencesOctober 24, 2023 | finance.yahoo.comFormer U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardOctober 24, 2023 | finance.yahoo.comFormer U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardSeptember 14, 2023 | finance.yahoo.comAlpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterAugust 29, 2023 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 28, 2023 | seekingalpha.comAlpha Tau Medical GAAP EPS of -$0.24, revenue of $12.26MAugust 18, 2023 | seekingalpha.comAlpha Tau gains on data for radiation therapyAugust 18, 2023 | benzinga.comThinking about buying stock in Alpha Tau Medical, IONQ, Novo Integrated Sciences, Vale SA, or Rivian Automotive?August 6, 2023 | finance.yahoo.comInsiders own 24% of Alpha Tau Medical Ltd. (NASDAQ:DRTS) shares but individual investors control 54% of the companyAugust 5, 2023 | fool.comAlpha Tau Medical (NASDAQ: DRTS)June 29, 2023 | finance.yahoo.comDRTS - Alpha Tau Medical Ltd.See More Headlines Receive DRTSW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:DRTSW CUSIPN/A CIK1871321 Webwww.alphatau.com Phone972 3 577 4115FaxN/AEmployees121Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Uzi Sofer (Age 54)CEO & Chairman Comp: $630kMr. Raphi Levy (Age 39)Chief Financial Officer Comp: $424kMr. Amnon Gat (Age 49)Chief Operations Officer Comp: $340kMr. Peter M. Melnyk (Age 62)Chief Commercial Officer Comp: $376kDr. Robert B. Den M.D. (Age 45)Chief Medical Officer & Member of Scientific Advisory Board Comp: $401kMr. Ronen Segal (Age 51)Chief Technology Officer Comp: $380kProf. Yona Keisari (Age 77)Chief Scientific Officer & Member of Scientific Advisory board Ms. Rebecca BeckerVice President of legalProf. Itzhak Kelson (Age 84)Chief Physics Officer & Member of Scientific Advisory Board Ms. Yael Zeiger (Age 41)Corporate Controller More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWBioCardiaNASDAQ:BCDAWView All Competitors DRTSW Stock Analysis - Frequently Asked Questions How have DRTSW shares performed in 2024? Alpha Tau Medical's stock was trading at $0.1926 on January 1st, 2024. Since then, DRTSW shares have increased by 28.5% and is now trading at $0.2475. View the best growth stocks for 2024 here. Are investors shorting Alpha Tau Medical? Alpha Tau Medical saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 8,200 shares, a decline of 60.4% from the May 15th total of 20,700 shares. Based on an average trading volume of 8,600 shares, the days-to-cover ratio is presently 1.0 days. View Alpha Tau Medical's Short Interest. How do I buy shares of Alpha Tau Medical? Shares of DRTSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DRTSW) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.